HomeNewsTrendsHealthMaharashtra govt warns of COVID-19 spike citing evasive XBB variant, winter

Maharashtra govt warns of COVID-19 spike citing evasive XBB variant, winter

A health official department bulletin said the XBB variant reported in the state had a "growth advantage over BA.2.75 and immune evasive property".

October 17, 2022 / 22:29 IST
Story continues below Advertisement
Representative image
Representative image

On the back of a 17.7 percent rise in coronavirus cases in Maharashtra this week when compared to last week, the state health department on Monday cited the XBB variant, found for the first time in the country, as well as winters and the festive season as factors that could fuel further spikes.

A health official department bulletin said the XBB variant reported in the state had a "growth advantage over BA.2.75 and immune evasive property". The BA.2.3.20 and BQ.1 variants have also been detected in the state, a first for the country, it added.

Story continues below Advertisement

It said new COVID-19 cases rose by 17.17 percent in the October 10-16 period when compared to last week between October 3 and 9, with the rise being noticed particularly in densely-populated Thane, Raigad, and Mumbai. "Some experts are predicting a rise (in cases) in the coming winter season, especially in festive environs," the bulletin cautioned.

It said the proportion of BA.2.75, an Omicron sub-variant, among cases detected had decreased from 95 percent to 76 percent. The state health department said people must not ignore flu-like symptoms and should get medical advice at the earliest.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show